Navigation Links
Millennium Laboratories Announces New Chief Operating Officer David Cohen
Date:8/30/2010

SAN DIEGO, Aug. 30 /PRNewswire/ -- Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain, announced today the appointment of David Cohen to Chief Operating Officer. In his capacity as COO, Mr. Cohen is responsible for new business analysis and development to expand the Company's core business. He also has oversight of Millennium's legislative initiatives and community outreach programs.

(Photo: http://photos.prnewswire.com/prnh/20100830/LA56535)

(Photo: http://www.newscom.com/cgi-bin/prnh/20100830/LA56535)

"David's track record of success in negotiation fund raising, SEC compliance and investor relations brings tremendous value to Millennium," said James Slattery, Chief Executive Officer. "His experience has already contributed greatly to our expansive growth and enhanced our reputation in the pain management arena."

"It's an honor to take on this new challenge at Millennium and to build on the momentum created by our new marketing, sales and operational initiatives," stated Cohen. "Our customer focus and emphasis on groundbreaking research position us to take Millennium to the next level."

David Cohen originally joined Millennium Laboratories as Chief Analytics Officer. In his 28-year career, Mr. Cohen has served as a public company Chief Financial Officer, Controller and later Executive Vice president of a $500 million dollar real estate conglomerate operating in 38 states and the commonwealth of Guam. He has also been involved with several start-ups and turnaround situations. His reputation as a skilled negotiator is well-earned – he has raised more than $35 million for specific projects in private and public offerings.

He has a Bachelor of Science degree in both Economics and Accounting. A Certified Public Accountant, Mr. Cohen has twice been licensed by the National Association of Securities Dealers (NASD) as a Financial Operations Principal.

About Millennium Laboratories

Millennium Laboratories, Inc. is a national, research-based medication monitoring company whose test panels, technology, customer support, educational resources and experts are specifically focused on clinicians who treat chronic pain.  The company has the only major Urine Drug Testing (UDT) laboratory exclusively utilizing the latest cutting-edge technology, Liquid Chromatography/Mass Spectrometry/Mass Spectrometry (LC-MS/MS). This allows Millennium to provide the fastest turn-around time in the industry for determining the presence and precise levels of drugs in a patient's urine, usually in one business day.

Located in San Diego's life sciences cluster, Millennium offers pain management practitioners industry-leading test accuracy in conjunction with clinical decision support through its RADAR Hotline 12 hours every business day.  Millennium is the only reference laboratory certified as a training facility for toxicology scientists and operates as a unique research component of the University of California, San Diego's (UCSD) doctoral program in Pharmacy. Millennium serves as an industry, government and payer educator and a compassionate advocate for chronic pain sufferers throughout the United States. The company is accredited by The Joint Commission, receiving the Gold Seal of Approval™ for healthcare quality and safety.  For more information, visit the Millennium Laboratories website, www.becausepainmatters.com.


'/>"/>
SOURCE Millennium Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Millennium Laboratories, Inc. Urges Medicare to Reconsider the 2010 Physician Reimbursement for Point-of-Care Urine Drug Screen Devices
2. Millennium Pharmacy Expands in New Jersey
3. Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group
4. Reprocessed Catheters: A Growing Force In the US Electrophysiology Diagnostic Catheter Market, According to Millennium Research Group
5. Millennium Pharmacy Adds First Client in New England
6. Global Spinal Nonfusion Market to Reach Almost $2 Billion By 2013, According to Millennium Research Group
7. $500 Billion Health Care Spend Boosts BRIC Countries Diagnostic Imaging Sales Despite Global Recession, According to Millennium Research Group
8. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
9. Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium
10. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
11. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):